FDA Inspection
Goran Pharma Private LtdGoran Pharma Private Ltd – FDA Inspection, Nov 15, 2017
Record Details
This FDA Inspection record concerns Goran Pharma Private Ltd, with an inspection on November 15, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7a3b56b3-bc62-422f-8a3c-e60ff11022d7
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1031932
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
18- 21 CFR 211.103Actual vs. theoretical yields not determined
- 21 CFR 211.22(b)Adequate lab facilities not available
- 21 CFR 211.166(b)Adequate number of batches on stability
- 21 CFR 211.28(a)Clothing appropriate for duties performed
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.65(a)Equipment construction - reactive surfaces
- 21 CFR 211.84(d)(2)Establish reliability of supplier"s C of A
- 21 CFR 211.125(d)Destruction of excess labels with lot numbers
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.170(b)Annual visual exams of drug products
Showing 10 of 18 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Goran Pharma Private Ltd
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 28, 2025 | Not classified | Office of Inspections and Investigations | |
| December 12, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Goran Pharma Private Ltd
- FDA Inspection 1266698 - 2025-02-28
- FDA Inspection 1115061 - 2019-12-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.